Your browser doesn't support javascript.
loading
HIV incidence in South African blood donors from 2012 to 2016: a comparison of estimation methods.
Vermeulen, Marion; Chowdhury, Dhuly; Swanevelder, Ronel; Grebe, Eduard; Brambilla, Donald; Jentsch, Ute; Busch, Michael; Van Zyl, Gert; Murphy, Edward L.
Afiliação
  • Vermeulen M; The South African National Blood Service, Roodepoort, South Africa.
  • Chowdhury D; Research Triangle Institute, Rockville, MD, USA.
  • Swanevelder R; The South African National Blood Service, Roodepoort, South Africa.
  • Grebe E; Vitalant Research Institute, San Francisco, CA, USA.
  • Brambilla D; Research Triangle Institute, Rockville, MD, USA.
  • Jentsch U; The South African National Blood Service, Roodepoort, South Africa.
  • Busch M; Vitalant Research Institute, San Francisco, CA, USA.
  • Van Zyl G; Stellenbosch University, Cape Town, South Africa.
  • Murphy EL; Vitalant Research Institute, San Francisco, CA, USA.
Vox Sang ; 116(1): 71-80, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32762088
ABSTRACT

BACKGROUND:

Measuring incidence is important for monitoring and maintaining the safety of the blood supply. Blood collected from repeat-donors has provided the opportunity to follow blood donors over time and has been used to estimate the incidence of viral infections. These incidence estimates have been extrapolated to first-time donors using the ratio of NAT yield cases in first-time versus repeat-donors. We describe a model to estimate incidence in first-time donors using the limiting antigen (LAg) avidity assay and compare its results with those from established models.

METHODS:

HIV-positive first-time donations were tested for recency using the LAg assay. Three models were compared; incidence estimated for (1) first-time donors using LAg avidity, (2) first-time and repeat-donors separately using the NAT yield window period (WP) model and (3) repeat-donors using the incidence/WP model.

RESULTS:

HIV incidence in first-time donors was estimated at 3·32 (CI 3·11, 3·55) and 3·81 (CI 3·07, 4·73) per 1000 PY using the LAg assay and NAT yield WP models, respectively. Incidence in repeat-donors was between 2·0- and 2·5-fold lower than in first-time donors estimated at 1·56 (CI 1·37, 1·77) and 1·94 (CI 1·86-2·01) per 1000 PY using the NAT yield/WP and incidence/WP models, respectively.

CONCLUSION:

Testing HIV-positive donations using the LAg assay provides a reliable method to estimate incidence in first-time donors for countries that collect the majority of blood from first-time donors and do not screen with NAT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Sangue / Infecções por HIV Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Vox Sang Ano de publicação: 2021 Tipo de documento: Article País de afiliação: África do Sul

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Sangue / Infecções por HIV Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Vox Sang Ano de publicação: 2021 Tipo de documento: Article País de afiliação: África do Sul